Prescott Group Capital Management’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-122,796
Closed -$785K 239
2025
Q1
$785K Sell
122,796
-308,704
-72% -$2.98M 0.11% 169
2024
Q4
$5.13M Buy
+431,500
New +$7.36M 0.7% 36
2023
Q2
Sell
-260,766
Closed -$1.94M 164
2023
Q1
$1.94M Sell
260,766
-528,708
-67% -$5.26M 0.45% 65
2022
Q4
$9.31M Buy
+789,474
New +$9.02M 2.03% 6
2022
Q3
Sell
-959,049
Closed -$9.47M 144
2022
Q2
$9.47M Buy
+959,049
New +$19.4M 2.53% 6

Other funds holding ASPN

Prescott Group Capital Management's ASPN Position: Q2 2025 in Review

Prescott Group Capital Management sold out of Aspen Aerogels (ASPN) in Q2 2025, closing a stake of 122,796 shares — an estimated $785K sold.

Prescott Group Capital Management first reported a position in ASPN in Q2 2022 and held it in 5 quarters. The position peaked at $9.47M in Q2 2022. 182 funds tracked by Wall St. Rank hold ASPN as of Q2 2025.

  • Prescott Group Capital Management reported no remaining Aspen Aerogels position as of Q2 2025 after selling out during the quarter.
  • Prescott Group Capital Management sold 122,796 Aspen Aerogels shares in Q2 2025, an estimated $785K.
  • Prescott Group Capital Management first reported a position in Aspen Aerogels in Q2 2022 and held it in 5 quarters.
  • Prescott Group Capital Management's Aspen Aerogels position peaked at $9.47M in Q2 2022.
  • 182 funds tracked by Wall St. Rank held Aspen Aerogels as of Q2 2025.

Based on Prescott Group Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.